BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 25457210)

  • 1. Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection.
    Huang CF; Dai CY; Yeh ML; Huang CI; Tai CM; Hsieh MH; Liang PC; Lin YH; Hsieh MY; Yang HL; Huang JF; Lin ZY; Chen SC; Yu ML; Chuang WL
    J Hepatol; 2015 Mar; 62(3):512-8. PubMed ID: 25457210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Variant in PNPLA3 Associated With Fibrosis Progression but not Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection.
    Ali M; Yopp A; Gopal P; Beg MS; Zhu H; Lee W; Singal AG
    Clin Gastroenterol Hepatol; 2016 Feb; 14(2):295-300. PubMed ID: 26305067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C.
    Valenti L; Rumi M; Galmozzi E; Aghemo A; Del Menico B; De Nicola S; Dongiovanni P; Maggioni M; Fracanzani AL; Rametta R; Colombo M; Fargion S
    Hepatology; 2011 Mar; 53(3):791-9. PubMed ID: 21319195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C.
    Manchiero C; Nunes AKDS; Magri MC; Dantas BP; Mazza CC; Barone AA; Tengan FM
    BMC Infect Dis; 2017 Dec; 17(1):780. PubMed ID: 29258449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C.
    Yasui K; Kawaguchi T; Shima T; Mitsuyoshi H; Seki K; Sendo R; Mizuno M; Itoh Y; Matsuda F; Okanoue T
    J Gastroenterol; 2015 Aug; 50(8):887-93. PubMed ID: 25543233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma in Asian chronic hepatitis C patients: A longitudinal study.
    Yen YH; Tsai MC; Wu CK; Chang KC; Hung CH; Chiu KW; Lu SN; Wang JH; Chen CH; Kee KM; Kuo YH; Tseng PL; Lin MT; Huang CM; Lin JT; Hu TH
    J Formos Med Assoc; 2018 Sep; 117(9):833-840. PubMed ID: 29089161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger age.
    Senkerikova R; Frankova S; Jirsa M; Kreidlova M; Merta D; Neroldova M; Chmelova K; Spicak J; Sperl J
    PLoS One; 2019; 14(9):e0222609. PubMed ID: 31527889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C.
    Sagnelli C; Merli M; Uberti-Foppa C; Hasson H; Cirillo G; Grandone A; Salpietro S; Minichini C; Del Giudice EM; Lazzarin A; Sagnelli E; Coppola N
    Clin Microbiol Infect; 2016 Apr; 22(4):372-378. PubMed ID: 26806136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the association of a variant in PNPLA3 and TM6SF2 with fibrosis progression in patients with chronic hepatitis C infection after eradication: A retrospective study.
    Kang Q; Xu J; Luo H; Tan N; Chen H; Cheng R; Pan J; Han Y; Yang Y; Liu D; Xi H; Yu M; Xu X
    Gene; 2022 Apr; 820():146235. PubMed ID: 35143946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PNPLA3 rs738409 Polymorphism Associated with Hepatic Steatosis and Advanced Fibrosis in Patients with Chronic Hepatitis C Virus: A Meta-Analysis.
    Fan JH; Xiang MQ; Li QL; Shi HT; Guo JJ
    Gut Liver; 2016 May; 10(3):456-63. PubMed ID: 26419236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
    Li JF; Zheng EQ; Xie M
    Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PNPLA3 rs738409 polymorphism is associated with liver fibrosis progression in patients with chronic hepatitis C: A repeated measures study.
    Jiménez-Sousa MÁ; Gómez-Moreno AZ; Pineda-Tenor D; Sánchez-Ruano JJ; Fernández-Rodríguez A; Artaza-Varasa T; Gómez-Sanz A; Martín-Vicente M; Vázquez-Morón S; Resino S
    J Clin Virol; 2018 Jun; 103():71-74. PubMed ID: 29674183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of patatin-like phospholipase domain-containing 3 gene polymorphism (rs738409) on severity of liver disease in HIV/hepatitis C virus-coinfected patients.
    Jiménez-Sousa MA; Berenguer J; García-Álvarez M; Gutierrez-Rivas M; Aldámiz-Echevarria T; Tejerina F; Diez C; Vázquez-Morón S; Resino S
    AIDS; 2016 Jan; 30(3):465-70. PubMed ID: 26760234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PNPLA3 and RNF7 Gene Variants are Associated with the Risk of Developing Liver Fibrosis and Cirrhosis in an Eastern European Population.
    Kupcinskas J; Valantiene I; Varkalaitė G; Steponaitiene R; Skieceviciene J; Sumskiene J; Petrenkiene V; Kondrackiene J; Kiudelis G; Lammert F; Kupcinskas L
    J Gastrointestin Liver Dis; 2017 Mar; 26(1):37-43. PubMed ID: 28338112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of PNPLA3 (rs738409 C>G) polymorphisms on liver histology and long-term clinical outcome in chronic hepatitis B patients.
    Brouwer WP; van der Meer AJ; Boonstra A; Pas SD; de Knegt RJ; de Man RA; Hansen BE; ten Kate FJ; Janssen HL
    Liver Int; 2015 Feb; 35(2):438-47. PubMed ID: 25284145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PNPLA3 genetic variants determine hepatic steatosis in non-obese chronic hepatitis C patients.
    Huang CF; Chen JJ; Yeh ML; Huang CI; Hsieh MY; Yang HL; Dai CY; Huang JF; Lin ZY; Chen SC; Chuang WL; Chen YL; Yu ML
    Sci Rep; 2015 Jul; 5():11901. PubMed ID: 26139292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C.
    Trépo E; Pradat P; Potthoff A; Momozawa Y; Quertinmont E; Gustot T; Lemmers A; Berthillon P; Amininejad L; Chevallier M; Schlué J; Kreipe H; Devière J; Manns M; Trépo C; Sninsky J; Wedemeyer H; Franchimont D; Moreno C
    Hepatology; 2011 Jul; 54(1):60-9. PubMed ID: 21488075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C.
    Zampino R; Coppola N; Cirillo G; Boemio A; Pisaturo M; Marrone A; Macera M; Sagnelli E; Perrone L; Adinolfi LE; Miraglia del Giudice E
    J Viral Hepat; 2013 Aug; 20(8):517-23. PubMed ID: 23808989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C.
    Petta S; Vanni E; Bugianesi E; Rosso C; Cabibi D; Cammà C; Di Marco V; Eslam M; Grimaudo S; Macaluso FS; McLeod D; Pipitone RM; Abate ML; Smedile A; George J; Craxì A
    Aliment Pharmacol Ther; 2015 May; 41(10):939-48. PubMed ID: 25801076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C.
    Stättermayer AF; Rutter K; Beinhardt S; Scherzer TM; Stadlmayr A; Hofer H; Wrba F; Steindl-Munda P; Krebs M; Datz C; Trauner M; Ferenci P
    J Hepatol; 2012 Sep; 57(3):492-8. PubMed ID: 22634340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.